Medtronic Europe — Gross notional amount increased by 358.7% to $21.10B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 234.9%, from $6.30B to $21.10B.
An increase suggests higher hedging activity to mitigate currency or interest rate risk, while a decrease may indicate reduced exposure or a change in risk management strategy.
This metric represents the total gross notional value of financial instruments, typically derivatives like foreign excha...
Comparable to derivative notional amounts reported by other multinational medical device firms with significant geographic revenue exposure.
mdt_segment_europe_gross_notional_amount| Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.90B | $5.00B | $4.80B | $5.40B | $5.40B | $5.40B | $5.40B | $6.30B | $5.70B | $4.70B | $4.60B | $21.10B |
| QoQ Change | — | +2.0% | -4.0% | +12.5% | +0.0% | +0.0% | +0.0% | +16.7% | -9.5% | -17.5% | -2.1% | +358.7% |
| YoY Change | — | — | — | — | +10.2% | +8.0% | +12.5% | +16.7% | +5.6% | -13.0% | -14.8% | +234.9% |